I am excited to share with you the announcement of a new strategic collaboration between Revvity Signals and Scitara while highlighting three key aspects of this partnership: Revvity Signals – Scitara Press Release
- Revvity Signals has embraced Scitara DLX as their integration platform of choice to digitally transform R&D labs into truly interconnected modern laboratories.
- Revvity Signals customers in pharma, biotech and industrial markets worldwide will now have access to Scitara DLX through their global sales, service and support organization.
- Scitara DLX will augment the capabilities of the Revvity Signals Research suite by integrating instruments, other informatics systems, devices and virtually any other lab resources. The combined solution will allow users to orchestrate even the most complex data workflows, integrate, curate, and annotate disparate data sets into AI-ready data repositories, and provide R&D scientists with new insights to drive faster decision-making.
Today is a very exciting day for Scitara and global R&D scientists. We are proud to partner with Revvity Signals.
Ajit Nagral, CEO Scitara